Advertisement
Advertisement

SPRO

SPRO logo

Spero Therapeutics, Inc. Common Stock

2.10
USD
Sponsored
-0.05
-2.33%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

2.10

0.00
+0.05%

Spero Therapeutics, Inc. Common Stock Profile

About

Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.

Info & Links

CEO

Esther Rajavelu

Headquarters

675 Massachusetts Avenue, 14th Floor
Cambridge, MA 02139, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://sperotherapeutics.com

Auditor

PricewaterhouseCoopers LLP

Share holders

8

Employees

25

Spero Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

121.65M

Enterprise Value

65.52M

Enterprise Value/EBITDA(ttm)

4.85

Price to Earnings Ratio(ttm)

23.17

Price to Sales(ttm)

2.41

Price to Book(mrq)

2.65

Price to Cash(ytd)

18.27

Profitability

Gross Margin(ttm)

100.00%

Operating Margin(ttm)

12.83%

Profit Margin(ttm)

-76.84%

Return on Equity(ttm)

22.53%

Return on Invested Capital(ttm)

-20.64%

Return on Assets(ttm)

13.04%

Income Statement

Revenue(ttm)

61.19M

Revenue Per Share(ttm)

1.06

Gross Profit(ttm)

61.19M

EBITDA(ttm)3

13.51M

Net Income Available to Common(ttm)

15.24M

Diluted EPS(ttm)

0.12

Share Statistics

Beta (5Y Monthly)

1.45

52-Week Change

-27.08%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

57.90M

Dividend Yield

0.00%

Float4

54.71M

% Held by Insiders

5.50%

% Held by Institutions

25.60%

Balance Sheet

Total Cash(mrq)

56.13M

Total Cash Per Share(mrq)

0.97

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.59%

Quick Ratio(mrq)

7.59%

Book Value Per Share(mrq)

1.05

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.21

Free Cash Flow(ytd)

-12.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement